Bausch Health Companies Inc. buy Vassago1
Start price
08.11.16
/
50%
€14.01
Target price
08.05.17
€15.33
Performance (%)
-37.00%
End price
08.05.17
€8.83
Summary
This prediction ended on 08.05.17 with a price of €8.83. The BUY prediction by Vassago1 for Bausch Health Companies Inc. performed very badly with a performance of -37.00%. Vassago1 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bausch Health Companies Inc. | -3.850% | -3.850% | -31.600% | -53.740% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by Vassago1 for this prediction
In the thread Bausch Health Companies Inc. diskutieren
VRX
The Canadian firm now expects adjusted earnings of $5.30 to $5.50 a share on $9.55 billion to $9.65 billion in sales for the year. That is down sharply from its previous guidance for earnings of $6.60 to $7 a share and revenue between $9.9 billion and $10.1 billion.
(Laufzeit überschritten)